Home Blog

AstraZeneca commits to supply Europe with 400 million doses of COVID-19 vaccine candidate

COVID-19 vaccine, global medicines supply chain, Google Cloud Designed, Supply Chain Managers, digital supply chain, lockdown bites, logistics, and manufacturing, astrazeneca vaccine, astrazeneca cure, astrazeneca covid19
AstraZeneca has announced that it has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA) to supply the continent with up to 400 million doses of the University of Oxford’s COVID-19 vaccine candidate (ChAdOx1 nCoV-19, now known as AZD1222), with deliveries starting by the end of 2020. With the new agreement, the IVA aims to accelerate the supply of...

BioSerenity, Leader in Healthcare as a Service (HaaS), Helps Advance Understanding of COVID-19 Neurological Impact

Covid-19 vaccines, Cancer Immunotherapy, Convalescent Plasma Therapy, cheap steroid, Cell therapy, COVID-19-associated ARDS, COVID-19 Neurological Impact, COVID-19 Patients, FDA.
BioSerenity offers EEG services using remotely connected equipment enabling testing outside of traditional departments.   Hospitals in France requested BioSerenity to perform EEGs in Intensive Care Units (ICUs) during the initial surge of Covid-19 patients. The data was reviewed remotely by BioSerenity's specialists and shared with the hospitals' medical staff. Via these collaborations, we were one of the first...

Israeli Researchers Say Medical Cannabis Could Effectively Treat Some COVID-19 Symptoms

Cannabinoids, CBD, Controlled substances, Marijuana, Cannabis, CBD Current news, medicinal cannabis industry, CBD and heart health, Smoking marijuana, COVID-19, medical marijuana.
Israeli researchers from The Medical Cannabis Research and Innovation Center at Haifa’s Rambam Health Care Campus are leading research that suggests the effects of medical cannabis could be used as a method for treating some symptoms of seriously ill COVID-19 patients. As the novel coronavirus continues to spread, clinical trials at Rambam hospital for the use of medical marijuana...

COVID-19 second peak could see almost 10 million patients waiting for NHS services, according to new tool

A free online waiting list estimation tool for NHS patients has predicted that almost 10 million people could be waiting for NHS services by the end of the year if there is a second peak of the COVID-19 virus. The tool, by UK digital hospital Medbelle, uses publicly available data published by the NHS to estimate waiting lists for...

Redhill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK

Redhill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK Mark L. Levitt, M.D., Ph.D., and Medical Director at Redhill, said: “We are quickly advancing the preparations for a global, multi-center powered Phase 2/3 study with opaganib for COVID-19. In line with the global shift from a focus on compassionate use programs to adequately...

Coronavirus Has Exposed the UK Dramatically

Fight against COVID-19, coronavirus battle, Virtual COVID-19 Clinic, COVID-19 voice detection apps, COVID-19 via electronic bracelets, treating COVID-19, digital health, COVID-19 triage screenings, COVID-19 related apps.
Roundup: Tech's role in tracking, testing, treating COVID-19 The digital health communities release a slew of new tools aiming to monitor the spread of the disease and facilitate better treatment. And it sounds as if there's still more to come, as just this morning CNBC reported that tech giants Facebook, Amazon and Google were sitting down with the World Health...

FDA Continues to Accelerate Development of Novel Therapies for COVID-19

COVID-19 Therapies, covid-19, vaccines, Novel Therapies for COVID-19, Antibodies Therapy, AI to seek combination therapies, Microneedle patches, COVID-19 therapeutics
Companies Taking Very Different Approaches to ACE2-Focused COVID-19 Therapies ACE2, which stands for angiotensin-converting enzyme-2, in healthy people, cuts up to two forms of the angiotensin protein to stabilize blood pressure, as well as other functions. SARS-CoV-2 attaches to ACE2, letting itself into the cell, where it then replicates itself in the cell. Usually, ACE2 is found on the lung,...

Vaccine Development for Covid-19

Coronavirus drug discovery, drug development, coronavirus treatment, coronavirus vaccine, Hydroxychloroquine, vaccine candidate, drugs for COVID-19, Advance COVID-19 Vaccine,
How is coronavirus vaccine development going in the U.S.? Delivery of the vaccine involved a microneedle array to increase potency. The fingertip-sized patch uses dissolvable needles – made of sugar and protein pieces – to deliver the virus’s spike protein into the skin, eliciting an immune response. Meanwhile, Janssen Pharmaceutical Co, a division of Johnson & Johnson, announced it will partner...

Hemp Companies Contribute to Fight against COVID-19 Crisis

Cannabinoids, CBD, Controlled substances, Marijuana, Cannabis, CBD Current news, Opioid Withdrawal Symptoms, CBD and arthritis pain, Medical Marijuana Cards, COVID-19 pandemic, COVID-19 Crisis.
COVID-19 Crisis Triggers Changes in Marijuana Consumer Behavior It’s safe to say the world has never experienced something quite like the Coronavirus pandemic. Three months after appearing in Wuhan, China, the virus has infected more than 1.4 million individuals worldwide and claimed at least 87,000 lives. Countries have had to radically overhaul systems that have been in place for decades...

As Coronavirus Cases Spike, Washington Marijuana Dispensaries Permitted to Remain Open

Coronavirus pandemic, opioid epidemic, CBD coronavirus, marijuana, COVID-19, marijuana home cultivation, vaping CBD, Coronavirus.
Washington Marijuana Dispensaries Permitted to Remain Open As the cases of coronavirus continue to climb in the United States of America, the cannabis dispensaries in Washington have been permitted to remain operational. However, the state Governor Jay Inslee on Monday has ordered the closure of non-essential businesses. Jay Inslee has issued the directive of staying at home to check the...